SCHEMBL6382462

SCHEMBL6382462

N#CC(NC(=O)[C@H]1CCCC[C@H]1NC(=O)Cc1ccc(Cl)cc1)C1CC1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.48
▸ LMNA P02545 1/20 0.45
▸ TDP1 Q9NUW8 2/20 0.40
▸ CNR2 P34972 1/20 0.39
▸ GRM7 Q14831 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ SIGMAR1 Q99720 3/20 0.38
▸ CCR1 P32246 2/20 0.37
▸ TACR1 P25103 1/20 0.37
▸ CTSC P53634 4/20 0.37
▸ KCNH2 Q12809 2/20 0.37
▸ AVPR1A P37288 2/20 0.37
▸ CTSK P43235 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6382470 1.00 POLB (0.48) POLBLMNATDP1CNR2GRM7
SCHEMBL6382465 1.00 POLB (0.48) POLBLMNATDP1CNR2GRM7
SCHEMBL6384080 0.78 ADAM17 (0.40) POLBCTSK
SCHEMBL6381865 0.78 ADAM17 (0.40) POLBCTSK
SCHEMBL6381866 0.78 ADAM17 (0.40) POLBCTSK
SCHEMBL6379903 0.78 POLB (0.64) POLBLMNATDP1GRM7ALDH1A1
SCHEMBL6379907 0.78 POLB (0.64) POLBLMNATDP1GRM7ALDH1A1
SCHEMBL6379897 0.78 POLB (0.64) POLBLMNATDP1GRM7ALDH1A1
SCHEMBL6839101 0.75 PSEN1 (0.48) CTSCKCNH2CTSK
SCHEMBL6381237 0.75 CASP3 (0.61) ALDH1A1KCNH2CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1294679-B1 BETA-AMINO ACID NITRILE DERIVATIVES HOFFMANN LA ROCHE (CH) 2005-09-21 — — EP claimed
EP-1294679-B1 BETA-AMINO ACID NITRILE DERIVATIVES HOFFMANN LA ROCHE (CH) 2005-09-21 — — EP disclosed
US-6462076-B2 CYSTEINE PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF DISEASES ASSOCIATED WITH CYSTEINE PROTEASES, SUCH AS OSTEOPOROSIS, OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, TUMOR METASTASIS, ANGINA PECTORIS, PLAQUE RUPTURE AND STROKE ETC. HOFFMANN-LA ROCHE INC. 2002-10-08 — — US disclosed
Send feedback